检查癌症患者的住院化疗利用率以及对结果的影响
Giulia Petrone1, Shivani Handa2, Justine Anderson3
1Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, United States.
住院系统疗法 (IST) 在固体瘤患者中经常被过度使用,导致结果差,死亡率高. 息护理 (PC) 改善了终身规划,但未得到充分利用.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 癌症护理越来越多地转移到门诊机构.
- 住院系统疗法 (IST) 与较差的生命终结结果有关.
- 需要指导方针来优化IST的使用.
研究的目的:
- 评估IST使用的原因.
- 评估IST接受者中息治疗 (PC) 的使用情况.
- 分析IST的结果,以提供临床指导方针.
主要方法:
- 对IST录取的回顾性图表审查 (2016年1月 - 2017年12月).
- 根据固体瘤 (ST) 与血液性恶性瘤 (HM) 的患者分层.
- 分析IST的紧迫性,响应,死亡率和PC使用情况.
主要成果:
- 在ST患者中,IST经常用于非紧急的指示.
- 与HM患者 (70%) 相比,ST患者对IST的反应率明显较低 (36%).
- 在ST患者中,PC利用率更高 (48%),并且与改善终身护理计划相关.
结论:
- 在ST患者中,IST被过度利用,反应不佳和高早期死亡率.
- 息护理 (PC) 服务未得到充分利用,但可以改善终身过渡计划.
- 需要进一步的研究来完善适合IST使用的指南.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
04:48Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
相关概念视频
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
